AlzeCure Pharma AB (FRA:AC6) Accounts Payable : €0.13 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is AlzeCure Pharma AB Accounts Payable?

AlzeCure Pharma AB's Accounts Payable for the quarter that ended in Sep. 2024 was €0.13 Mil.

AlzeCure Pharma AB's quarterly Accounts Payable declined from Mar. 2024 (€0.29 Mil) to Jun. 2024 (€0.20 Mil) and declined from Jun. 2024 (€0.20 Mil) to Sep. 2024 (€0.13 Mil).

AlzeCure Pharma AB's annual Accounts Payable declined from Dec. 2021 (€0.58 Mil) to Dec. 2022 (€0.44 Mil) and declined from Dec. 2022 (€0.44 Mil) to Dec. 2023 (€0.24 Mil).

AlzeCure Pharma AB Accounts Payable Historical Data

The historical data trend for AlzeCure Pharma AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzeCure Pharma AB Accounts Payable Chart

AlzeCure Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.29

0.39

0.58

0.44

0.24

AlzeCure Pharma AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															0.16	0.24	0.29	0.20	0.13

AlzeCure Pharma AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

AlzeCure Pharma AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of AlzeCure Pharma AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AlzeCure Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (FRA:AC6) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ALZCUR:Sweden

Address

Halsovagen 7, Huddinge, SWE, SE 141 57

Website

https://www.alzecurepharma.se

AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.

AlzeCure Pharma AB Headlines

No Headlines